Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders
Author:
Affiliation:
1. Department of Clinical Pharmacology, Idorsia Pharmaceuticals Ltd, Allschwil, Switzerland
2. Department of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland
Publisher
Informa UK Limited
Subject
Pharmacology,Toxicology,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.1080/17425255.2020.1817380
Reference144 articles.
1. Sleep and the Brain
2. Nighttime Insomnia Symptoms and Perceived Health in the America Insomnia Survey (AIS)
3. Diagnostic and Statistical Manual of Mental Disorders
4. The neurobiology, investigation, and treatment of chronic insomnia
5. European guideline for the diagnosis and treatment of insomnia
Cited by 62 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Sleep Disorders;Massachusetts General Hospital Comprehensive Clinical Psychiatry;2025
2. Factors associated with hypnotics polypharmacy in the Japanese population;Sleep Medicine;2024-10
3. From guidelines to bedside - insomnia treatment practices in South Korea: a nationwide cohort study;Frontiers in Psychiatry;2024-09-13
4. Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies;Journal of Sleep Research;2024-08-08
5. Association between the use of orexin receptor antagonists and falls or fractures: A meta-analysis;Journal of Psychiatric Research;2024-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3